PubRank

E C Douglass

Author PubWeight™ 81.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 1991 3.16
2 An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 1990 3.02
3 Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci U S A 1992 2.42
4 Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 1984 2.22
5 There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 1999 1.96
6 Amplification of the gli gene in childhood sarcomas. Cancer Res 1989 1.84
7 Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 2000 1.70
8 Isolation of transplantable erythroleukemia cells from mice infected with helper-independent Friend murine leukemia virus. Blood 1981 1.61
9 Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors. J Clin Oncol 1995 1.58
10 Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene 1990 1.53
11 Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity. Cancer 1995 1.49
12 Ability of circular extrachromosomal DNA molecules to carry amplified MYCN proto-oncogenes in human neuroblastomas in vivo. J Natl Cancer Inst 1990 1.38
13 Wilms' tumor: reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology. Int J Radiat Oncol Biol Phys 1990 1.38
14 Is renal salvage feasible in unilateral Wilms' tumor? Proposed computed tomographic criteria and their relation to surgicopathologic findings. Am J Pediatr Hematol Oncol 1990 1.38
15 Rhabdomyosarcoma complicating multiple neurofibromatosis. J Pediatr 1978 1.26
16 Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene 1994 1.25
17 High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol 1993 1.19
18 Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma. Cancer Res 1987 1.17
19 Comparison of constitutional and tumor-associated 11;22 translocations: nonidentical breakpoints on chromosomes 11 and 22. Proc Natl Acad Sci U S A 1986 1.16
20 Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res 1998 1.14
21 Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol 1993 1.13
22 Teratoid Wilms' tumor: the St Jude experience. J Pediatr Surg 1988 1.13
23 Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide. Cancer 1993 1.04
24 Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol 1994 1.04
25 Cytogenetic studies in non-African Burkitt lymphoma. Blood 1980 1.01
26 Oncogene amplification in pediatric brain tumors. Cancer Res 1990 0.99
27 Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms' tumor. J Clin Oncol 1986 0.95
28 Extrarenal Wilms' tumor. J Pediatr Surg 1989 0.92
29 Pediatric nasopharyngeal carcinoma: long term follow-up of 29 patients. Int J Radiat Oncol Biol Phys 1989 0.90
30 Primary malignant rhabdoid tumor of the brain: clinical, imaging, and pathologic findings. AJNR Am J Neuroradiol 1993 0.90
31 Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication. Br J Cancer 1993 0.89
32 Amplification of genes encoding human myeloid membrane antigens after DNA-mediated gene transfer. Blood 1986 0.89
33 Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol 1985 0.88
34 Closely linked loci on the long arm of chromosome 13 flank a specific 2;13 translocation breakpoint in childhood rhabdomyosarcoma. Cytogenet Cell Genet 1989 0.88
35 Chromosome 1 abnormalities: a common feature of pediatric solid tumors. J Natl Cancer Inst 1985 0.88
36 Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. J Natl Cancer Inst 1980 0.87
37 Abnormalities of chromosomes 1 and 11 in Wilms' tumor. Cancer Genet Cytogenet 1985 0.87
38 Evidence for genetic heterogeneity in familial Wilms' tumor. Cancer Res 1997 0.86
39 Molecular analysis of chromosome 1 abnormalities in neuroblastoma. Cytogenet Cell Genet 1989 0.86
40 Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors. Cancer 1994 0.86
41 Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphomas: evidence of occult bone marrow involvement. Blood 1983 0.86
42 t(11;22) and other chromosomal rearrangements in Ewing's sarcoma. J Natl Cancer Inst 1986 0.85
43 Fatal refractory hyperkalemia due to tumor lysis during primary resection for hepatoblastoma. J Pediatr Surg 1990 0.85
44 Cytogenetic studies in ovarian cancer. Cancer Genet Cytogenet 1984 0.85
45 Significance of pulmonary computed tomography at diagnosis in Wilms' tumor. J Clin Oncol 1988 0.85
46 Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol 1991 0.84
47 Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 1992 0.84
48 Solid alveolar rhabdomyosarcomas with the t(2;13). Report of two cases with diagnostic implications. Am J Surg Pathol 1994 0.83
49 Nonlinkage of 16q markers to familial predisposition to Wilms' tumor. Cancer Res 1992 0.83
50 In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins. Cancer Res 1985 0.82
51 Immunohistochemical and ultrastructural spectrum of hepatic sarcomas of childhood: evidence for a common histogenesis. Mod Pathol 1991 0.82
52 The first recurring chromosome translocation in hepatoblastoma: der(4)t(1;4)(q12;q34). Genes Chromosomes Cancer 1997 0.82
53 A phase I study of ifosfamide given on alternate days to treat children with brain tumors. Cancer 1993 0.82
54 Development and characterization of pediatric osteosarcoma xenografts. Cancer Res 1990 0.82
55 Bilateral Wilms tumor. Review of outcome, associated abnormalities, and late effects in 36 pediatric patients treated at a single institution. Cancer 1993 0.82
56 Phase II trial of ifosfamide in children with malignant solid tumors. Cancer Treat Rep 1987 0.81
57 A new cytogenetic finding in an epithelioid sarcoma, t(8;22)(q22;q11). Cancer Genet Cytogenet 1994 0.81
58 Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumors. Invest New Drugs 1986 0.81
59 Incontinentia pigmenti, a chromosomal instability syndrome, is associated with childhood malignancy. Cancer 1988 0.81
60 A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer. Gynecol Oncol 2003 0.80
61 Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: implications for the relationship between African and American Burkitt's lymphoma. Clin Immunol Immunopathol 1982 0.80
62 Fractures in children treated with radiotherapy for soft tissue sarcoma. Orthopedics 1996 0.80
63 Refining therapeutic strategies for patients with resistant Wilm's tumor. Am J Pediatr Hematol Oncol 1994 0.80
64 Embryonal malignancies of unknown primary origin in children. Cancer 1995 0.79
65 Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy. J Clin Oncol 1991 0.79
66 Ifosfamide in pediatric malignant solid tumors. Cancer Chemother Pharmacol 1989 0.79
67 Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity. N Engl J Med 1988 0.78
68 Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988. Semin Oncol 1989 0.78
69 Response of pediatric low grade gliomas to chemotherapy. Pediatr Neurosurg 1993 0.78
70 A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study. J Neurooncol 1995 0.78
71 The potential for renal salvage in nonmetastatic unilateral Wilms' tumor. Am J Pediatr Hematol Oncol 1991 0.78
72 Evidence for clonal development of Wilms' tumor. Am J Pediatr Hematol Oncol 1991 0.78
73 Serial cytogenetic studies of nonendemic Burkitt's lymphoma cell lines. J Natl Cancer Inst 1980 0.77
74 Receptor characteristics of the rat mammary carcinoma cell line 64-24. Cancer Res 1981 0.77
75 Development and characterization of human ependymoma xenograft HxBr5. Cancer Res 1987 0.77
76 Relapsed Wilms' tumor. Factors affecting survival and cure. Am J Clin Oncol 1985 0.76
77 Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study. J Clin Oncol 1990 0.76
78 Neuraxis dissemination in pediatric brain tumors. Response to preirradiation chemotherapy. Cancer 1992 0.76
79 Malignant rhabdoid tumor of the liver. Evidence for epithelial differentiation. Arch Pathol Lab Med 1988 0.76
80 High-activity 125I interstitial irradiation in the treatment of pediatric central nervous system tumors: a pilot study. Pediatr Neurosurg 1995 0.75
81 Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy. Med Pediatr Oncol 1994 0.75
82 Hypotetraploidy in erythroleukemia. Cancer Genet Cytogenet 1983 0.75
83 Use of HBA 71 and anti-beta 2-microglobulin to distinguish peripheral neuroepithelioma from neuroblastoma. Hum Pathol 1993 0.75
84 Der(16)t(1;16)(q21;q13) in Wilms' tumor: friend or foe. Med Pediatr Oncol 1996 0.75
85 Phase I study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumors. Am J Clin Oncol 1991 0.75
86 Relation of tumor-cell ploidy to survival in children with medulloblastoma. J Clin Oncol 1993 0.75
87 Relationship between chemical-induced fragile sites and chromosomal breakpoints in malignant cells in children. Leuk Lymphoma 1992 0.75
88 Reduced therapy for Wilms' tumor: analysis of treatment results from a single institution. J Clin Oncol 1988 0.75
89 The value of computerized tomography as a routine follow-up procedure for patients with Wilms' tumor. Med Pediatr Oncol 1984 0.75
90 A phase I study of ifosfamide with Mesna given daily for 3 consecutive days to children with malignant solid tumors. Cancer 1993 0.75
91 Burkitt cell leukemia without abnormalities of chromosomes No. 8 and 14. Cancer Genet Cytogenet 1982 0.75
92 Phase I study of 4'-deoxydoxorubicin (esorubicin) in children with malignant solid tumors. Invest New Drugs 1989 0.75